浸润性乳腺癌T2加权成像特征与临床病理特征及新辅助治疗结局的关联
回顾性纳入179例浸润性乳腺癌女性术前3T乳腺MRI,评估瘤内T2信号强度、瘤周水肿及T2弛豫时间,并与临床病理特征和68例接受新辅助化疗患者的疗效关联。结果显示较高瘤内T2信号、水肿分级和较长弛豫时间与较高临床T分期、激素受体阴性、三阴性亚型及新辅助化疗期间疾病进展相关。
要点
- 瘤内T2信号强度越高、瘤周水肿分级越高,T2弛豫时间越长(P<0.001)。
- 较高瘤内T2信号强度与较高临床T分期、腋窝淋巴结转移及多灶性相关(均P<0.05)。
- 较长瘤内T2弛豫时间与较高临床T分期、激素受体阴性和三阴性亚型相关(均P<0.05)。
核心结论
- T2加权MRI特征与临床T分期、激素受体状态、三阴性亚型及新辅助化疗期间疾病进展相关,但与病理完全缓解无显著关联。
研究设计与样本
- 回顾性研究,纳入179例浸润性乳腺癌女性,术前3T乳腺MRI(2020年11月至2021年2月),评估T2WI瘤内信号强度、瘤周水肿分级及含或不含坏死或囊性区域的T2弛豫时间;其中68例接受新辅助化疗。
关键影像表现/征象
- 瘤内T2信号强度和瘤周水肿分级越高,T2弛豫时间越长(P<0.001)。
- 较高瘤内T2信号强度与较高临床T分期、腋窝淋巴结转移及肿瘤多灶性相关(均P<0.05)。
- 较长瘤内T2弛豫时间与较高临床T分期、激素受体阴性和三阴性亚型相关(均P<0.05),排除坏死或囊性区域后仍存在。
- 较高瘤周水肿分级与较高临床T分期、激素受体阴性和三阴性亚型相关(均P<0.05)。
- 瘤周水肿T2弛豫时间除与较高临床T分期(P=0.005)和雌激素受体状态(P=0.030)相关外,无其他显著关联。
诊断标准与关键数值
- 瘤内T2信号强度分级越高,T2弛豫时间越长(P<0.001)。
- 新辅助化疗亚组中,较高瘤内T2信号强度分级和较长T2弛豫时间与化疗期间疾病进展显著相关(P<0.05)。
- 瘤周水肿与任何新辅助化疗结局均无显著关联(P>0.05)。
临床应用与阅片要点
- 阅片时对瘤内T2信号强度和瘤周水肿进行分级,可提示较高临床T分期、腋窝淋巴结转移及多灶性风险。
- 较长瘤内T2弛豫时间可能提示激素受体阴性或三阴性亚型,需结合病理。
- 接受新辅助化疗者,较高瘤内T2信号强度或较长弛豫时间可能提示疾病进展风险,但与病理完全缓解无关。
- 评估瘤周水肿的T2弛豫时间时,除临床T分期和雌激素受体状态外,未显示其他显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the associations between T2-weighted imaging (T2WI) features and clinicopathologic characteristics in invasive breast cancer, as well as their relationship with treatment response to neoadjuvant chemotherapy (NAC).
MATERIALS AND METHODS: This retrospective study included 179 women with invasive breast cancer who underwent preoperative 3T breast MRI between November 2020 and February 2021. Intratumoral T2 signal intensity (SI) and peritumoral edema were graded on T2WI, and T2 relaxation times were calculated both including and excluding necrotic or cystic areas. T2 relaxation times were compared across T2 SI grades using the Kruskal-Wallis test. Associations between T2 features and clinicopathologic factors were assessed using chi-square tests and logistic regression analyses. In patients who received NAC (n = 68), associations between T2 features and NAC outcomes were also evaluated.
RESULTS: Higher intratumoral T2 SI and peritumoral edema grades were significantly associated with longer T2 relaxation times (P < 0.001). Intratumoral T2 SI grades were associated with higher clinical T category, axillary lymph node metastasis, and tumor multiplicity (all P < 0.05). Longer intratumoral T2 relaxation times were associated with higher clinical T category, hormone receptor (HR) negativity, and the triple-negative subtype (all P < 0.05), even after excluding necrotic or cystic areas. Higher peritumoral edema grades were associated with advanced clinical T category, HR negativity, and the triple-negative subtype (all P < 0.05). T2 relaxation times of peritumoral edema showed no significant associations, except with higher clinical T category (P = 0.005) and estrogen receptor status (P = 0.030). In the NAC subgroup, higher intratumoral T2 SI grades and longer T2 relaxation times were significantly associated with disease progression during NAC (P < 0.05), but not with non-pathologic complete response. Peritumoral edema showed no significant association with NAC outcomes (P > 0.05).
CONCLUSION: T2-weighted MRI features were associated with clinicopathologic factors, including clinical T category, HR status, triple-negative subtype, and disease progression during NAC.
引用
- Youn I, Roh YH, Kim MJ, et al. Association of T2-Weighted Imaging Features in Invasive Breast Cancer With Clinicopathologic Features and Neoadjuvant Treatment Outcomes. Korean J Radiol. 2026. PMID: 41776852. doi:10.3348/kjr.2025.1382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。